Questions about a product, technology or experimental design? Give us a call 610-644-8845.

UP110: Monoubiquitylated Histone H2B Peptide

LifeSensors UP110 is a monoubiquitylated histone H2B peptide at lysine 120, used to study transcriptional regulation and epigenetic modifications in research.

$724.00

SKU UP-0110-0050 Category

In stock

  • DUB substrates for screening
  • Antigens for generation of site-specific ubiquitin antibodies
  • Structural studies of ubiquitin-binding domain recognition
Monoubiquitylation of lysine 120 on human histone H2B is associated with transcriptional activity. The RNF20/40 complex functions as the E3 ligase and UbcH6 as the E2 conjugating enzyme to monoubiquitinate this site to stimulate HOX gene expression. Monoubiquitylation of lysine 120 increases histone chaperone FACT function resulting in transcript elongation and the generation of longer transcripts. This monoubiquitylated peptide (Ac-AVSEGTKAVTK(ubiquitin)YTSSK-NH2) can be used for deubiquitylation assays or to study ubiquitin binding domain recognition. In contrast to traditional DUB substrates, like ubiquitin-AMC and ubiquitin-rhodamine, which measure cleavage of amide bonds, utilization of a monoubiquitylated peptide as a DUB substrate measures cleavage of an isopeptide bond and allows determination of the influence of sequence proximal to the ubiquitylated lysine on specificity.  

Info

Species Human
Source E. coli
Tag None
Molecular Weight 10,244.7 Da
Quantity 50 µg
Concentration Variable
Formulation Lyophilized powder
Storage -20 °C (dry);  -80°C (solution), avoid freeze/thaw cycles
  • DUB substrates for screening
  • Antigens for generation of site-specific ubiquitin antibodies
  • Structural studies of ubiquitin-binding domain recognition

send us a message for pricing

CONTACT INFORMATION

Phone (Office)

610.644.8845

SEND EMAIL

info@lifesensors.com

VISIT ANYTIME

271 Great Valley Parkway Malvern, PA 19355

More from This Category

PROTAC IS A REGISTERED TRADEMARK OF ARVINAS OPERATIONS, INC., AND IS USED UNDER LICENSE.